Literature DB >> 19120280

Toll-like receptors and diabetes.

F Susan Wong1, Li Wen.   

Abstract

Toll-like receptors (TLRs) recognize molecular patterns relating to a variety of microbial infections. Stimulation through TLRs leads to activation of antigen-presenting cells, production of inflammatory cytokines creating inflammation, and production of type 1 interferons (IFNs) that include IFN-alpha and -beta, and exerts direct effects on regulatory cells. These effects can direct the immune response, dealing with the immediate problems of infection and activating more specific responses of the adaptive immune system. However, it has recently been recognized that these receptors may recognize endogenous ligands that include DNA, RNA, and proteins that arise from cellular stress. This may have an effect on autoimmune responses in a number of ways, both activating and inhibitory. The means by which infection or endogenous stimuli through TLRs may influence autoimmunity will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120280     DOI: 10.1196/annals.1447.063

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  The 'hygiene hypothesis' for autoimmune and allergic diseases: an update.

Authors:  H Okada; C Kuhn; H Feillet; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 2.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

3.  Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.

Authors:  Mohan R Dasu; Ishwarlal Jialal
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

4.  Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood.

Authors:  Hyung-Sik Kim; Tae-Hoon Shin; Se-Ran Yang; Min-Soo Seo; Dong-Jae Kim; Soo-Kyung Kang; Jong-Hwan Park; Kyung-Sun Kang
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

Review 5.  Innate receptors and microbes in induction of autoimmunity.

Authors:  Alexander Chervonsky
Journal:  Curr Opin Immunol       Date:  2009-09-09       Impact factor: 7.486

6.  Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.

Authors:  Mohan R Dasu; Sridevi Devaraj; Samuel Park; Ishwarlal Jialal
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

7.  Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions.

Authors:  Shunsuke Takata; Yoshihiko Sawa; Takanobu Uchiyama; Hiroyuki Ishikawa
Journal:  Acta Histochem Cytochem       Date:  2013-02-15       Impact factor: 1.938

8.  Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation.

Authors:  Rasheed Ahmad; Anfal Al-Mass; Valerie Atizado; Asma Al-Hubail; Fahad Al-Ghimlas; Monira Al-Arouj; Abdullah Bennakhi; Said Dermime; Kazem Behbehani
Journal:  J Inflamm (Lond)       Date:  2012-11-28       Impact factor: 4.981

9.  Preliminary analysis of immune activation in early onset type 2 diabetes.

Authors:  Julia D Rempel; Juliet Packiasamy; Heather J Dean; Jonathon McGavock; Alyssa Janke; Mark Collister; Brandy Wicklow; Elizabeth A C Sellers
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

10.  Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.

Authors:  Yoshihiko Sawa; Shunsuke Takata; Yuji Hatakeyama; Hiroyuki Ishikawa; Eichi Tsuruga
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.